EGFR and colorectal cancer: Here we present the first GWAS to identify SNPs associated with EGFR inhibitor-induced skin toxicity using data of the multicenter randomized phase III CAIRO2 trial of the Dutch Colorectal Cancer Group (DCCG)[11].